Conference Coverage
Conference Coverage
Risk factors ID’d for acute pancreatitis from weight-loss drugs
“With obesity being such a global issue, there are many patients on these GLP-1 agonists.”
Conference Coverage
Early estrogen loss increases cardiovascular risk in women
Clinicians should especially be aware of functional hypothalamic amenorrhea as a condition that could increase women’s risk of cardiovascular...
Conference Coverage
Does exposure to cell phone Wi-Fi spell trouble for sperm?
Preliminary study hints that motility, viability could take a hit when devices are in pockets.
Conference Coverage
Stopping levothyroxine in subclinical hypothyroidism safe, feasible
Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism.
Conference Coverage
Achieving diversity, equity and inclusion: Invite everyone and build a team
Don’t recruit diverse people to your program and then have them come and feel not included.
Conference Coverage
Don’t be afraid of weight gain with hyperthyroid treatment
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
Conference Coverage
Drug repurposing ‘fast track’ to new medicines for obesity, diabetes
“We would like to progress some of these compounds to preclinical and clinical trials, but need to raise the funds for this expensive research.”...
Conference Coverage
Nonhormonal drug fezolinetant found safe for hot flashes in yearlong study
Although additional safety studies await fezolinetant before it heads to the FDA for approval, it appears to be on its way to offering women an...
Conference Coverage
Menopause symptoms negatively affect women’s work
With 13% of women reporting a major impact on their work from menopause symptoms, the study still may underestimate the effects of this life...
Latest News
Screening gaps miss childhood heart problems
Clinical diagnosis of homozygous familial hypercholesterolemia can be based on LDL cholesterol levels, family history, and the presence of...
Conference Coverage
Tirzepatide’s benefits expand: Lean mass up, serum lipids down
New results from the SURMOUNT-1 trial of tirzepatide in people with obesity show further positive effects.